Saol Therapeutics’ mission is to have a measurable impact on the health and wellbeing of underserved patient populations. To that end, Saol is aggressively seeking out and developing new therapeutic options to support clinicians around the world – and most importantly – the patients they serve.

Our growing pipeline consists of programs targeted for various treatments including chronic pain, musculoskeletal conditions, disorders of the central nervous system and rare diseases. In anticipation of multiple FDA approvals over the next three years, Saol continues to rapidly grow its organization, accelerating product development to enhance and expand treatment options for patients and providers around the world.

Additionally, Saol is interested in partnering with others who are looking to accelerate their growth by leveraging the talent and capability of our highly experienced and entrepreneurial organization.

To learn more about partnering with Saol, please visit our Business Development page.